The federal government is being urged to establish a new fund to support the commercialisation of diagnostics manufacturing in Australia to reduce dependence on US and European supply chains for the medical equipment.
In the wake of the COVID crisis, the Australian government has been looking to build sovereign manufacturing capability to increase its preparedness against a future pandemic by bolstering supply chains for local health needs.
MedBioTech and the pharmaceutical Industry Growth Centre MTPConnect, together with industry body Pathology Technology Australia on Monday published a diagnostic technology sovereign capability and resilience national action plan. More than 140 stakeholders participated in the consultation process that informed the action plan.
Want to know how this story ends?
Become a subscriber for complete access to all stories on InnovationAus.com and our daily newsletter.
Do you know more? Contact James Riley via Email.